Top

Gepubliceerd in:

2021 | OriginalPaper | Hoofdstuk

16. Middelgerelateerde en verslavingsstoornissen

Auteurs : Drs. Maaike van Veen, MSc, Dr. Roelof Risselada

Gepubliceerd in: Slaapstoornissen in de psychiatrie

Uitgeverij: Bohn Stafleu van Loghum

Samenvatting

Middelgerelateerde en verslavingsstoornissen zijn nauw verweven met verstoringen van het slaappatroon; zo zijn slaapproblemen op jongere leeftijd duidelijk voorspellend voor het ontwikkelen van een latere verslaving – en vice versa. Bovendien zijn slaapproblemen na het bereiken van abstinentie een belangrijke risicofactor voor terugval in gebruik. Wat de relatie tussen middelgerelateerde en verslavingsstoornissen en slaap extra complex maakt ten opzichte van comorbiditeit met overige psychiatrische aandoeningen, zijn de directe effecten van het gebruik van diverse middelen op de slaap, ontregeling van de slaap door het staken van middelengebruik, het aspect van zelfmedicatie en de ongunstige leefstijlpatronen. In de behandeling van patiënten met middelgerelateerde en verslavingsstoornissen is het belangrijk om al deze aspecten in overweging te nemen om zodoende de individuele diagnostiek en behandeling van slaapproblemen bij deze patiëntengroep te optimaliseren.

vorige hoofdstuk Autismespectrumstoornissen

volgende hoofdstuk Persoonlijkheidsstoornissen

Afshar, M., Knapp, C. M., Sarid-Segal, O., Devine, E., Colaneri, L. S., Tozier, L., et al. (2012). The efficacy of mirtazapine in the treatment of cocaine dependence with comorbid depression. The American Journal of Drug and Alcohol Abuse, 38(2), 181–186.PubMedPubMedCentralCrossRef

Anderson, C., & Platten, C. R. (2011). Sleep deprivation lowers inhibition and enhances impulsivity to negative stimuli. Behavioural Brain Research, 217(2), 463–466.PubMedCrossRef

Angarita, G. A., Canavan, S. V., Forselius, E., Bessette, A., Pittman, B., & Morgan, P. T. (2014). Abstinence-related changes in sleep during treatment for cocaine dependence. Drug and Alcohol Dependence, 134, 343–347.PubMedCrossRef

Angarita, G. A., Emadi, N., Hodges, S., & Morgan, P. T. (2016). Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: A comprehensive review. Addiction Science & Clinical Practice, 11(1), 9-016-0056-7.

Arnedt, J. T., Conroy, D. A., Armitage, R., & Brower, K. J. (2011). Cognitive-behavioral therapy for insomnia in alcohol dependent patients: A randomized controlled pilot trial. Behaviour Research and Therapy, 49(4), 227–233.PubMedPubMedCentralCrossRef

Baandrup, L., Ebdrup, B. H., Rasmussen, J. O., Lindschou, J., Gluud, C., & Glenthoj, B. Y. (2018). Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users. The Cochrane Database of Systematic Reviews, 3, CD011481.

Babson, K. A., Ramo, D. E., Baldini, L., Vandrey, R., & Bonn-Miller, M. O. (2015). Mobile app-delivered cognitive behavioral therapy for insomnia: Feasibility and initial efficacy among veterans with cannabis use disorders. JMIR Research Protocols, 4(3), e87.PubMedPubMedCentralCrossRef

Babson, K. A., Sottile, J., & Morabito, D. (2017). Cannabis, cannabinoids, and sleep: A review of the literature. Current Psychiatry Reports, 19(4), 23-017-0775-9.

Banz, B. C., Yip, S. W., Yau, Y. H., & Potenza, M. N. (2016). Behavioral addictions in addiction medicine: From mechanisms to practical considerations. Progress in Brain Research, 223, 311–328.PubMedCrossRef

Barros, V. V., Opaleye, E. S., Demarzo, M., Bowen, S., Curado, D. F., Hachul, H., et al. (2018). Dispositional mindfulness, anticipation and abstinence symptoms related to hypnotic dependence among insomniac women who seek treatment: A cross-sectional study. PLoS ONE, 13(3), e0194035.PubMedPubMedCentralCrossRef

Bastien, C. H., LeBlanc, M., Carrier, J., & Morin, C. M. (2003). Sleep EEG power spectra, insomnia, and chronic use of benzodiazepines. Sleep, 26(3), 313–317.PubMedCrossRef

Bonn-Miller, M. O., Babson, K. A., & Vandrey, R. (2014). Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with PTSD. Drug and Alcohol Dependence, 136, 162–165.PubMedCrossRef

Bootzin, R. R., & Stevens, S. J. (2005). Adolescents, substance abuse, and the treatment of insomnia and daytime sleepiness. Clinical Psychology Review, 25(5), 629–644.PubMedCrossRef

Breslau, N., Roth, T., Rosenthal, L., & Andreski, P. (1996). Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young adults. Biological Psychiatry, 39(6), 411–418.PubMedCrossRef

Brower, K. J. (2015). Assessment and treatment of insomnia in adult patients with alcohol use disorders. Alcohol (Fayetteville, N.Y.), 49(4), 417–427.

Brower, K. J., Aldrich, M. S., Robinson, E. A., Zucker, R. A., & Greden, J. F. (2001). Insomnia, self-medication, and relapse to alcoholism. The American Journal of Psychiatry, 158(3), 399–404.PubMedPubMedCentralCrossRef

Brower, K. J., & Perron, B. E. (2010). Sleep disturbance as a universal risk factor for relapse in addictions to psychoactive substances. Medical Hypotheses, 74(5), 928–933.PubMedCrossRef

Brown, R. E., Basheer, R., McKenna, J. T., Strecker, R. E., & McCarley, R. W. (2012). Control of sleep and wakefulness. Physiological Reviews, 92(3), 1087–1187.PubMedCrossRef

Cardullo, S., Gomez Perez, L. J., Marconi, L., Terraneo, A., Gallimberti, L., Bonci, A., & Madeo, G. (2019). Clinical improvements in comorbid Gambling/Cocaine use disorder (GD/CUD) patients undergoing repetitive transcranial magnetic stimulation (rTMS). Journal of Clinical Medicine, 8(6), https://doi.org/10.3390/jcm8060768.

Caviness, C. M., Anderson, B. J., & Stein, M. D. (2019). Impact of nicotine and other stimulants on sleep in young adults. Journal of Addiction Medicine, 13(3), 209–214.PubMedCrossRef

Chakravorty, S., Chaudhary, N. S., & Brower, K. J. (2016). Alcohol dependence and its relationship with insomnia and other sleep disorders. Alcoholism, Clinical and Experimental Research, 40(11), 2271–2282.PubMedPubMedCentralCrossRef

Chakravorty, S., Hanlon, A. L., Kuna, S. T., Ross, R. J., Kampman, K. M., Witte, L. M., et al. (2014). The effects of quetiapine on sleep in recovering alcohol-dependent subjects: A pilot study. Journal of Clinical Psychopharmacology, 34(3), 350–354.PubMedCrossRef

Chakravorty, S., Morales, K. H., Arnedt, J. T., Perlis, M. L., Oslin, D. W., Findley, J. C., et al. (2019). Cognitive behavioral therapy for insomnia in alcohol-dependent veterans: A randomized, controlled pilot study. Alcoholism, Clinical and Experimental Research, 43(6), 1244–1253.PubMedPubMedCentral

Clark, I., & Landolt, H. P. (2017). Coffee, caffeine, and sleep: A systematic review of epidemiological studies and randomized controlled trials. Sleep Medicine Reviews, 31, 70–78.PubMedCrossRef

Conroy, D. A., & Arnedt, J. T. (2014). Sleep and substance use disorders: An update. Current Psychiatry Reports, 16(10), 487-014-0487-3.

Cornelius, J. R., Chung, T., Douaihy, A. B., Kirisci, L., Glance, J., Kmiec, J., et al. (2016). Mirtazapine in comorbid major depression and an alcohol use disorder: A double-blind placebo-controlled pilot trial. Psychiatry Research, 242, 326–330.PubMedPubMedCentralCrossRef

Crowe, S. F., & Stranks, E. K. (2018). The residual medium and long-term cognitive effects of benzodiazepine use: An updated meta-analysis. Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists, 33(7), 901–911.CrossRef

Darker, C. D., Sweeney, B. P., Barry, J. M., Farrell, M. F., & Donnelly-Swift, E. (2015). Psychosocial interventions for benzodiazepine harmful use, abuse or dependence. The Cochrane Database of Systematic Reviews, (5):CD009652.

Didriksen, M., Rigas, A. S., Allen, R. P., Burchell, B. J., Di Angelantonio, E., Nielsen, M. H., et al. (2017). Prevalence of restless legs syndrome and associated factors in an otherwise healthy population: Results from the danish blood donor study. Sleep Medicine, 36, 55–61.PubMedCrossRef

Dijkstra, B., Van Oort, M., Schellekens, A., De Haan, H., & De Jong, C. (2017). Richtlijn detoxificatie van psychoactieve middelen. Kenniscentrum Verslaving, Amersfoort: Stichting Resultaten scoren.

Dolsen, M. R., & Harvey, A. G. (2017). Life-time history of insomnia and hypersomnia symptoms as correlates of alcohol, cocaine and heroin use and relapse among adults seeking substance use treatment in the united states from 1991 to 1994. Addiction, 112(6), 1104–1111.PubMedPubMedCentralCrossRef

Dom, G., Van Den Brink, W., & Schellekens, A. (2018). Gepersonaliseerde behandeling bij stoornissen in het gebruik van alcohol en tabak. Tijdschrift voor Psychiatrie, 60(3), 166–173.

Drake, C. L., Jefferson, C., Roehrs, T., & Roth, T. (2006). Stress-related sleep disturbance and polysomnographic response to caffeine. Sleep Medicine, 7(7), 567–572.PubMedPubMedCentralCrossRef

DSM-5 (2017). Beknopt overzicht van de criteria DSM-5. Nederlandse vertaling van Desk reference to the diagnostic criteria from DSM-5. American Psychiatric Association.

Du, X., Xu, W., Li, X., Zhou, D., & Han, C. (2019). Sleep disorder in drug addiction: Treatment with transcranial magnetic stimulation. Frontiers in Psychiatry, 10, 848.PubMedPubMedCentralCrossRef

Ducci, F., & Goldman, D. (2012). The genetic basis of addictive disorders. The Psychiatric Clinics of North America, 35(2), 495–519.PubMedPubMedCentralCrossRef

Dumont, G. J. H. (2010). Cannabis en het endocannabinoïdsysteem. Psyfar, (2). Prelum uitgevers.

Dunn, K. E., Finan, P. H., Andrew Tompkins, D., & Strain, E. C. (2018). Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients. Addictive Behaviors, 76, 8–14.PubMedCrossRef

Dvorakova, K., Kishida, M., Li, J., Elavsky, S., Broderick, P. C., Agrusti, M. R., et al. (2017). Promoting healthy transition to college through mindfulness training with first-year college students: Pilot randomized controlled trial. Journal of American College Health: Journal of ACH, 65(4), 259–267.CrossRef

Ferre, S., Garcia-Borreguero, D., Allen, R. P., & Earley, C. J. (2019). New insights into the neurobiology of restless legs syndrome. The Neuroscientist: A Review Journal Bringing Neurobiology, Neurology and Psychiatry, 25(2), 113–125.CrossRef

Fortuna, L. R., Cook, B., Porche, M. V., Wang, Y., Amaris, A. M., & Alegria, M. (2018). Sleep disturbance as a predictor of time to drug and alcohol use treatment in primary care. Sleep Medicine, 42, 31–37.PubMedPubMedCentralCrossRef

Friedmann, P. D., Rose, J. S., Swift, R., Stout, R. L., Millman, R. P., & Stein, M. D. (2008). Trazodone for sleep disturbance after alcohol detoxification: A double-blind, placebo-controlled trial. Alcoholism, Clinical and Experimental Research, 32(9), 1652–1660.PubMedPubMedCentralCrossRef

George, O., & Koob, G. F. (2017). Individual differences in the neuropsychopathology of addiction. Dialogues in Clinical Neuroscience, 19(3), 217–229.PubMedPubMedCentralCrossRef

Gibson, M., Munafo, M. R., Taylor, A. E., & Treur, J. L. (2019). Evidence for genetic correlations and bidirectional, causal effects between smoking and sleep behaviors. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco, 21(6), 731–738.CrossRef

Gordon, H. W. (2019). Differential effects of addictive drugs on sleep and sleep stages. Journal of Addiction Research (OPAST Group), 3(2), 10.33140.

Goyal, M., Singh, S., Sibinga, E. M., Gould, N. F., Rowland-Seymour, A., Sharma, R., et al. (2014). Meditation programs for psychological stress and well-being: A systematic review and meta-analysis. JAMA Internal Medicine, 174(3), 357–368.PubMedPubMedCentralCrossRef

Grant, J. E., Odlaug, B. L., & Chamberlain, S. R. (2017). Gambling disorder, DSM-5 criteria and symptom severity. Comprehensive Psychiatry, 75, 1–5.PubMedPubMedCentralCrossRef

Griesar, W. S., Zajdel, D. P., & Oken, B. S. (2002). Nicotine effects on alertness and spatial attention in non-smokers. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco, 4(2), 185–194.CrossRef

Gujar, N., Yoo, S. S., Hu, P., & Walker, M. P. (2011). Sleep deprivation amplifies reactivity of brain reward networks, biasing the appraisal of positive emotional experiences. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 31(12), 4466–4474.CrossRef

Haney, M., Cooper, Z. D., Bedi, G., Herrmann, E., Comer, S. D., Reed, S. C., et al. (2019). Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers. Addiction Biology, 24(4), 707–716.PubMedCrossRef

Hartwell, E. E., Pfeifer, J. G., McCauley, J. L., Moran-Santa Maria, M., & Back, S. E. (2014). Sleep disturbances and pain among individuals with prescription opioid dependence. Addictive Behaviors, 39(10), 1537–1542.PubMedPubMedCentralCrossRef

Hasler, B. P., Casement, M. D., Sitnick, S. L., Shaw, D. S., & Forbes, E. E. (2017). Eveningness among late adolescent males predicts neural reactivity to reward and alcohol dependence 2 years later. Behavioural Brain Research, 327, 112–120.PubMedPubMedCentralCrossRef

He, S., Brooks, A. T., Kampman, K. M., & Chakravorty, S. (2019). The relationship between alcohol craving and insomnia symptoms in alcohol-dependent individuals. Alcohol and Alcoholism (Oxford, Oxfordshire), 54(3), 287–294.CrossRef

Hendriks, V., Blanken, P., Croes, E., Schippers, G., Schellekens, A., Stollenga, M., Van den Brink, W. (2018). Multidisciplinaire richtlijn: Stoornissen in het gebruik van cannabis, cocaïne, amfetamine, ecstasy, GHB en benzodiazepines.

Horne, J. A. (1993). Human sleep, sleep loss and behaviour. implications for the prefrontal cortex and psychiatric disorder. The British Journal of Psychiatry: The Journal of Mental Science, 162, 413–419.CrossRef

Jaehne, A., Loessl, B., Barkai, Z., Riemann, D., & Hornyak, M. (2009). Effects of nicotine on sleep during consumption, withdrawal and replacement therapy. Sleep Medicine Reviews, 13(5), 363–377.PubMedCrossRef

James, M. H., Mahler, S. V., Moorman, D. E., & Aston-Jones, G. (2017). A decade of Orexin/Hypocretin and addiction: Where are we now? Current Topics in Behavioral Neurosciences, 33, 247–281.PubMedPubMedCentralCrossRef

Jesse, S., Brathen, G., Ferrara, M., Keindl, M., Ben-Menachem, E., Tanasescu, R., et al. (2017). Alcohol withdrawal syndrome: Mechanisms, manifestations, and management. Acta Neurologica Scandinavica, 135(1), 4–16.PubMedCrossRef

Karsten, J., & Lancel, M. (2014). Invloed van benzodiazepines, zolpidem en zopiclon op de slaap. Psyfar, (3). Prelum uitgevers.

Khusid, M. A., & Vythilingam, M. (2016). The emerging role of mindfulness meditation as effective self-management strategy, part 2: Clinical implications for chronic pain, substance misuse, and insomnia. Military Medicine, 181(9), 969–975.PubMedCrossRef

Koob, G. F., & Colrain, I. M. (2020). Alcohol use disorder and sleep disturbances: A feed-forward allostatic framework. Neuropsychopharmacology, 45, 141–165.

Krishnan, V., Dixon-Williams, S., & Thornton, J. D. (2014). Where there is smoke … there is sleep apnea: Exploring the relationship between smoking and sleep apnea. Chest, 146(6), 1673–1680.

Kruisdijk, F., Hopman-Rock, M., Beekman, A. T. F., & Hendriksen, I. (2019). EFFORT-D: Results of a randomised controlled trial testing the EFFect of running therapy on depression. BMC Psychiatry, 19(1), 170-019-2156-x.

Lam, T., Ogeil, R. P., Allsop, S., Chikritzhs, T., Fischer, J., Midford, R., et al. (2018). Insomnia and regulation of sleep-wake cycle with drugs among adolescent risky drinkers. Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine, 14(9), 1529–1537.

Logan, R. W., Hasler, B. P., Forbes, E. E., Franzen, P. L., Torregrossa, M. M., Huang, Y. H., et al. (2018). Impact of sleep and circadian rhythms on addiction vulnerability in adolescents. Biological Psychiatry, 83(12), 987–996.PubMedCrossRef

Lowe, H., Haddock, G., Mulligan, L. D., Gregg, L., Fuzellier-Hart, A., Carter, L. A., et al. (2019). Does exercise improve sleep for adults with insomnia? A systematic review with quality appraisal. Clinical Psychology Review, 68, 1–12.PubMedCrossRef

Mackie, S. E., & Winkelman, J. W. (2017). Therapeutic utility of opioids for restless legs syndrome. Drugs, 77(12), 1337–1344.PubMedCrossRef

Manconi, M., Ferri, R., Miano, S., Maestri, M., Bottasini, V., Zucconi, M., et al. (2017). Sleep architecture in insomniacs with severe benzodiazepine abuse. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology, 128(6), 875–881.CrossRef

Marzullo, P., Menegatti, M., Guzzaloni, G., Fanari, P., Uccelli, E., Tagliaferri, M. A., et al. (2013). Cocaine abuse and sleep apnea in severe obesity. Journal of Addiction Medicine, 7(4), 294–295.PubMedCrossRef

Mason, M., Cates, C. J., & Smith, I. (2015). Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea. Cochrane Database of Systematic Reviews, 7, CD011090.

Mason, B. J., Quello, S., & Shadan, F. (2018). Gabapentin for the treatment of alcohol use disorder. Expert Opinion on Investigational Drugs, 27(1), 113–124.PubMedCrossRef

Mazza, M., Losurdo, A., Testani, E., Marano, G., Di Nicola, M., Dittoni, S., et al. (2014). Polysomnographic findings in a cohort of chronic insomnia patients with benzodiazepine abuse. Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine, 10(1), 35–42.

McKenna, B. S., Dickinson, D. L., Orff, H. J., & Drummond, S. P. (2007). The effects of one night of sleep deprivation on known-risk and ambiguous-risk decisions. Journal of Sleep Research, 16(3), 245–252.PubMedCrossRef

McKetin, R., Lubman, D. I., Najman, J. M., Dawe, S., Butterworth, P., & Baker, A. L. (2014). Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study. Addiction, 109(5), 798–806.PubMedCrossRef

Miller, M. B., Janssen, T., & Jackson, K. M. (2017). The prospective association between sleep and initiation of substance use in young adolescents. The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine, 60(2), 154–160.CrossRef

Mondino, A., Cavelli, M., Gonzalez, J., Santana, N., Castro-Zaballa, S., Mechoso, B., et al. (2019). Acute effect of vaporized cannabis on sleep and electrocortical activity. Pharmacology, Biochemistry and Behavior, 179, 113–123.PubMedCrossRef

Morgan, P. T., Pace-Schott, E., Pittman, B., Stickgold, R., & Malison, R. T. (2010). Normalizing effects of modafinil on sleep in chronic cocaine users. The American Journal of Psychiatry, 167(3), 331–340.PubMedPubMedCentralCrossRef

Motomura, Y., Kitamura, S., Nakazaki, K., Oba, K., Katsunuma, R., Terasawa, Y., et al. (2017). Recovery from unrecognized sleep loss accumulated in daily life improved mood regulation via prefrontal suppression of amygdala activity. Frontiers in Neurology, 8, 306.PubMedPubMedCentralCrossRef

Muller, K. W., Beutel, M. E., & Wolfling, K. (2019). Decreased occupational functioning and increased physical health complaints in treatment seekers with internet-related disorders: Compared to patients with gambling disorder. European Addiction Research, 25(5), 229–237.PubMedCrossRef

Muller, H., Seifert, F., Maler, J. M., Kornhuber, J., & Sperling, W. (2012). Agomelatine reduces craving in benzodiazepine addicts: A follow-up examination of three patients. Singapore Medical Journal, 53(11), e228–e230.PubMed

Nelson, A. M., Battersby, A. S., Baghdoyan, H. A., & Lydic, R. (2009). Opioid-induced decreases in rat brain adenosine levels are reversed by inhibiting adenosine deaminase. Anesthesiology, 111(6), 1327–1333.PubMedCrossRef

Niesink, R., & Van Laar, M. (2012). THC, CBD en gezondheidseffecten van wiet en hasj: recente inzichten. Utrecht: Trimbos-instituut.

O’Callaghan, F., Muurlink, O., & Reid, N. (2018). Effects of caffeine on sleep quality and daytime functioning. Risk Management and Healthcare Policy, 11, 263–271.PubMedPubMedCentralCrossRef

Ogeil, R. P., & Phillips, J. G. (2015). Commonly used stimulants: Sleep problems, dependence and psychological distress. Drug and Alcohol Dependence, 153, 145–151.PubMedCrossRef

Ohayon, M. M., & Roth, T. (2002). Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. Journal of Psychosomatic Research, 53(1), 547–554.PubMedCrossRef

Onaolapo, O. J., & Onaolapo, A. Y. (2018). Melatonin in drug addiction and addiction management: Exploring an evolving multidimensional relationship. World Journal of Psychiatry, 8(2), 64–74.PubMedPubMedCentralCrossRef

Panin, F., & Peana, A. T. (2019). Sleep and the pharmacotherapy of alcohol use disorder: Unfortunate bedfellows. A systematic review with meta-analysis. Frontiers in Pharmacology, 10, 1164.

Parhami, I., Siani, A., Rosenthal, R. J., & Fong, T. W. (2013). Pathological gambling, problem gambling and sleep complaints: An analysis of the national comorbidity survey: Replication (NCS-R). Journal of Gambling Studies, 29(2), 241–253.PubMedPubMedCentralCrossRef

Park, K. M., Kim, T. H., Kim, W. J., An, S. K., Namkoong, K., & Lee, E. (2018). Cognitive behavioral therapy for insomnia reduces hypnotic prescriptions. Psychiatry Investigation, 15(5), 499–504.PubMedPubMedCentralCrossRef

Passos, G. S., Poyares, D. L., Santana, M. G., Tufik, S., & Mello, M. T. (2012). Is exercise an alternative treatment for chronic insomnia? Clinics (Sao Paulo, Brazil), 67(6), 653–660.CrossRef

Saint-Mleux, B., Eggermann, E., Bisetti, A., Bayer, L., Machard, D., Jones, B. E., et al. (2004). Nicotinic enhancement of the noradrenergic inhibition of sleep-promoting neurons in the ventrolateral preoptic area. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 24(1), 63–67.CrossRef

Sangroula, D., Motiwala, F., Wagle, B., Shah, V. C., Hagi, K., & Lippmann, S. (2017). Modafinil treatment of cocaine dependence: A systematic review and meta-analysis. Substance Use and Misuse, 52(10), 1292–1306.PubMedCrossRef

Schierenbeck, T., Riemann, D., Berger, M., & Hornyak, M. (2008). Effect of illicit recreational drugs upon sleep: Cocaine, ecstasy and marijuana. Sleep Medicine Reviews, 12(5), 381–389.PubMedCrossRef

Sivertsen, B., Omvik, S., Pallesen, S., Nordhus, I. H., & Bjorvatn, B. (2009). Sleep and sleep disorders in chronic users of zopiclone and drug-free insomniacs. Journal of Clinical Sleep Medicine, 5(4), 349–354.PubMedPubMedCentralCrossRef

Sivertsen, B., Skogen, J. C., Jakobsen, R., & Hysing, M. (2015). Sleep and use of alcohol and drug in adolescence. A large population-based study of norwegian adolescents aged 16 to 19 years. Drug and Alcohol Dependence, 149, 180–186.PubMedCrossRef

Stein, M. D., Kurth, M. E., Anderson, B. J., & Blevins, C. E. (2020). A pilot crossover trial of sleep medications for sleep-disturbed methadone maintenance patients. Journal of Addiction Medicine, 14(2), 126–131.PubMedCrossRef

Stein, M. D., Kurth, M. E., Sharkey, K. M., Anderson, B. J., Corso, R. P., & Millman, R. P. (2012). Trazodone for sleep disturbance during methadone maintenance: A double-blind, placebo-controlled trial. Drug and Alcohol Dependence, 120(1–3), 65–73.PubMedCrossRef

Takaesu, Y., Utsumi, T., Okajima, I., Shimura, A., Kotorii, N., Kuriyama, K., et al. (2019). Psychosocial intervention for discontinuing benzodiazepine hypnotics in patients with chronic insomnia: A systematic review and meta-analysis. Sleep Medicine Reviews, 48, 101214.PubMedCrossRef

Taylor, H. L., Rybarczyk, B. D., Nay, W., & Leszczyszyn, D. (2015). Effectiveness of a CBT intervention for persistent insomnia and hypnotic dependency in an outpatient psychiatry clinic. Journal of Clinical Psychology, 71(7), 666–683.PubMedCrossRef

Teran, A., Majadas, S., & Galan, J. (2008). Quetiapine in the treatment of sleep disturbances associated with addictive conditions: A retrospective study. Substance Use and Misuse, 43(14), 2169–2171.PubMedCrossRef

Valentino, R. J., & Volkow, N. D. (2020). Drugs, sleep, and the addicted brain. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 45(1), 3–5.CrossRef

Van den Brink, W., Dom, G., Dumont, G. J. H., Neven, A., & Schellekens, A. (2019). Farmacotherapie bij verslaving. Prelum uitgevers.

Van Gordon, W., Shonin, E., & Griffiths, M. D. (2016). Meditation awareness training for the treatment of sex addiction: A case study. Journal of Behavioral Addictions, 5(2), 363–372.PubMedPubMedCentralCrossRef

Van Laar, M. W., & Gestel, B. V. (2017). Nationale drug monitor. Trimbos-instituut.

Venkatraman, V. (2007). Sleep deprivation elevates expectation of gains and attenuates response to losses following risky decisions. Sleep, 30(5), 603–609.PubMedCrossRef

Vernon, L., Modecki, K. L., & Barber, B. L. (2018). Mobile phones in the bedroom: Trajectories of sleep habits and subsequent adolescent psychosocial development. Child Development, 89(1), 66–77.PubMedCrossRef

Vickers-Smith, R., Sun, J., Charnigo, R. J., Lofwall, M. R., Walsh, S. L., & Havens, J. R. (2020). Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system. Drug and Alcohol Dependence, 206, 107709.PubMedCrossRef

Volkow, N. D., Koob, G. F., & McLellan, A. T. (2016). Neurobiologic advances from the brain disease model of addiction. The New England Journal of Medicine, 374(4), 363–371.PubMedPubMedCentralCrossRef

Volkow, N. D., Wang, G. J., Logan, J., Alexoff, D., Fowler, J. S., Thanos, P. K., et al. (2015). Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain. Translational Psychiatry, 5, e549.PubMedPubMedCentralCrossRef

Watson, C. J., Lydic, R., & Baghdoyan, H. A. (2007). Sleep and GABA levels in the oral part of rat pontine reticular formation are decreased by local and systemic administration of morphine. Neuroscience, 144(1), 375–386.PubMedCrossRef

Webb, I. C. (2017). Circadian rhythms and substance abuse: Chronobiological considerations for the treatment of addiction. Current Psychiatry Reports, 19(2), 12-017-0764-z.

Wiers, C. E., Shumay, E., Cabrera, E., Shokri-Kojori, E., Gladwin, T. E., Skarda, E., et al. (2016). Reduced sleep duration mediates decreases in striatal D2/D3 receptor availability in cocaine abusers. Translational Psychiatry, 6, e752.PubMedPubMedCentralCrossRef

Wise, R. A., & Koob, G. F. (2014). The development and maintenance of drug addiction. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 39(2), 254–262.CrossRef

Wisselink, D. J., Kuijpers, W. G. T., & Mol, A. (2016). Kerncijfers verslavingszorg 2015. Landelijk alcohol en drugs informatie systeem (LADIS). Houten: SIVZ.

Wong, M. M., Brower, K. J., & Zucker, R. A. (2009). Childhood sleep problems, early onset of substance use and behavioral problems in adolescence. Sleep Medicine, 10(7), 787–796.PubMedPubMedCentralCrossRef

Yoo, S. S., Gujar, N., Hu, P., Jolesz, F. A., & Walker, M. P. (2007). The human emotional brain without sleep–a prefrontal amygdala disconnect. Current Biology, 17(20), R877–R878.PubMedCrossRef

Zhand, N., & Milin, R. (2018). What do we know about the pharmacotherapeutic management of insomnia in cannabis withdrawal: A systematic review. The American Journal on Addictions, 27(6), 453–464.PubMedCrossRef

Zhang, J. J. Q., Fong, K. N. K., Ouyang, R. G., Siu, A. M. H., & Kranz, G. S. (2019). Effects of repetitive transcranial magnetic stimulation (rTMS) on craving and substance consumption in patients with substance dependence: A systematic review and meta-analysis. Addiction, 114(12), 2137–2149.PubMedCrossRef

Zorginstituut Nederland (2020). Farmacotherapeutisch Kompas. Beschikbaar via https://farmacotherapeutischkompas.nl. Laatst geraadpleegd 31 januari 2020.

Titel: Middelgerelateerde en verslavingsstoornissen
Auteurs: Drs. Maaike van Veen, MSc
Dr. Roelof Risselada
Uitgeverij: Bohn Stafleu van Loghum
Boek: Slaapstoornissen in de psychiatrie
Print ISBN: 978-90-368-2523-8

Elektronisch ISBN: 978-90-368-2524-5

Copyright: 2021
DOI: https://doi.org/10.1007/978-90-368-2524-5_16

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen